Zobrazeno 1 - 10
of 15
pro vyhledávání: '"COVID-19 Vaccines/immunology"'
Systems serology detects functionally distinct coronavirus antibody features in children and elderly
Autor:
Allen C. Cheng, Francesca L Mordant, Katherine Kedzierska, Keith J. Chappell, Daniel Watterson, Brendon Y. Chua, Hannah G. Kelly, Suzanne K. Shoffner, Jane Crowe, Carolien E. van de Sandt, Melissa M. Lemke, Naphak Modhiran, Bruce D. Wines, Fatima Amanat, Thi H. O. Nguyen, Adam K. Wheatley, Marios Koutsakos, Wen Shi Lee, Hyon-Xhi Tan, Luca Hensen, Kelly B. Arnold, David C. Jackson, Paul R. Young, Amy W. Chung, Paul V. Licciardi, Katie L. Flanagan, Shidan Tosif, Samantha K Davis, Louise C. Rowntree, Chinn Yi Wong, Jennifer A Juno, Stephen J. Kent, Nigel W Crawford, P. Mark Hogarth, Philip Sutton, Melanie R Neeland, Robyn Esterbauer, Kevin J. Selva, Florian Krammer, Denise L. Doolan, Christina Lee
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Nature Communications, 12(1):2037
Nature Communications
Nature communications, 12(1). Nature Publishing Group
Nature Communications, 12(1):2037
Nature Communications
Nature communications, 12(1). Nature Publishing Group
The hallmarks of COVID-19 are higher pathogenicity and mortality in the elderly compared to children. Examining baseline SARS-CoV-2 cross-reactive immunological responses, induced by circulating human coronaviruses (hCoVs), is needed to understand su
Autor:
Crommelin, Daan J A, Volkin, David B, Hoogendoorn, Karin H, Lubiniecki, Anthony S, Jiskoot, Wim, Afd Pharmaceutics, Pharmaceutics
Publikováno v:
Journal of Pharmaceutical Sciences, 110(2), 627. John Wiley and Sons Inc.
Journal of Pharmaceutical Sciences
Journal of Pharmaceutical Sciences, 110(2), 627-634. ELSEVIER SCIENCE INC
Journal of Pharmaceutical Sciences
Journal of Pharmaceutical Sciences, 110(2), 627-634. ELSEVIER SCIENCE INC
Once Covid-19 vaccines become available, 5-10 billion vaccine doses should be globally distributed, stored and administered. In this commentary, we discuss how this enormous challenge could be addressed for viral vector-based Covid-19 vaccines by lea
Autor:
Hall, Victoria, Foulkes, Sarah, Insalata, Ferdinando, Kirwan, Peter, Saei, Ayoub, Atti, Ana, Wellington, Edgar, Khawam, Jameel, Munro, Katie, Cole, Michelle, Tranquillini, Caio, Taylor-Kerr, Andrew, Hettiarachchi, Nipunadi, Calbraith, Davina, Sajedi, Noshin, Milligan, Iain, Themistocleous, Yrene, Corrigan, Diane, Cromey, Lisa, Price, Lesley, Stewart, Sally, De Lacy, Elen, Norman, Chris, Linley, Ezra, Otter, Ashley D, Semper, Amanda, Hewson, Jacqueline, D'Arcangelo, Silvia, Chand, Meera, Brown, Colin S, Brooks, Tim, Islam, Jasmin, Charlett, Andre, Hopkins, Susan, SIREN Study Group
Supported by the U.K. Health Security Agency, the U.K. Department of Health and Social Care (with contributions from the governments in Northern Ireland, Wales, and Scotland), the National Institute for Health Research, and grants from the Medical Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b284cab213361250d5ff8ce3e14262
https://www.repository.cam.ac.uk/handle/1810/340961
https://www.repository.cam.ac.uk/handle/1810/340961
Autor:
Ole Schmeltz Søgaard, Joanne Reekie, Isik Somuncu Johansen, Henrik Nielsen, Thomas Benfield, Lothar Wiese, Nina Breinholt Stærke, Kasper Iversen, Kamille Fogh, Jacob Bodilsen, Mette Iversen, Lene Surland Knudsen, Vibeke Klastrup, Fredrikke Dam Larsen, Sidsel Dahl Andersen, Astrid Korning Hvidt, Signe Rode Andreasen, Lone Wulff Madsen, Susan Olaf Lindvig, Anne Øvrehus, Sisse Rye Ostrowski, Christiane Abildgaard, Charlotte Matthews, Tomas O. Jensen, Dorthe Raben, Christian Erikstrup, Thea K. Fischer, Martin Tolstrup, Lars Østergaard, Jens Lundgren
Publikováno v:
Søgaard, O S, Reekie, J, Johansen, I S, Nielsen, H, Benfield, T, Wiese, L, Stærke, N B, Iversen, K, Fogh, K, Bodilsen, J, Iversen, M, Knudsen, L S, Klastrup, V, Larsen, F D, Andersen, S D, Hvidt, A K, Andreasen, S R, Madsen, L W, Lindvig, S O, Øvrehus, A, Ostrowski, S R, Abildgaard, C, Matthews, C, Jensen, T O, Raben, D, Erikstrup, C, Fischer, T K, Tolstrup, M, Østergaard, L & Lundgren, J 2022, ' Characteristics Associated with Serological Covid-19 Vaccine Response and Durability in an Older Population with Significant Comorbidity : The Danish Nationwide ENFORCE Study ', Clinical Microbiology and Infection, vol. 28, no. 8, pp. 1126-1133 . https://doi.org/10.1016/j.cmi.2022.03.003
Søgaard, O S, Reekie, J, Johansen, I S, Nielsen, H, Benfield, T, Wiese, L, Stærke, N B, Iversen, K, Fogh, K, Bodilsen, J, Iversen, M, Knudsen, L S, Klastrup, V, Larsen, F D, Andersen, S D, Hvidt, A K, Andreasen, S R, Madsen, L W, Lindvig, S O, Øvrehus, A, Ostrowski, S R, Abildgaard, C, Matthews, C, Jensen, T O, Raben, D, Erikstrup, C, Fischer, T K, Tolstrup, M, Østergaard, L, Lundgren, J & ENFORCE Writing Group 2022, ' Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity : the Danish Nationwide ENFORCE Study ', Clinical Microbiology and Infection, vol. 28, no. 8, pp. 1126-1133 . https://doi.org/10.1016/j.cmi.2022.03.003
Søgaard, O S, Reekie, J, Johansen, I S, Nielsen, H, Benfield, T, Wiese, L, Stærke, N B, Iversen, K, Fogh, K, Bodilsen, J, Iversen, M, Knudsen, L S, Klastrup, V, Larsen, F D, Andersen, S D, Hvidt, A K, Andreasen, S R, Madsen, L W, Lindvig, S O, Øvrehus, A, Ostrowski, S R, Abildgaard, C, Matthews, C, Jensen, T O, Raben, D, Erikstrup, C, Fischer, T K, Tolstrup, M, Østergaard, L, Lundgren, J & ENFORCE Writing Group 2022, ' Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity : the Danish Nationwide ENFORCE Study ', Clinical Microbiology and Infection, vol. 28, no. 4, pp. 1126-1133 . https://doi.org/10.1016/j.cmi.2022.03.003
Søgaard, O S, Reekie, J, Johansen, I S, Nielsen, H, Benfield, T, Wiese, L, Stærke, N B, Iversen, K, Fogh, K, Bodilsen, J, Iversen, M, Knudsen, L S, Klastrup, V, Larsen, F D, Andersen, S D, Hvidt, A K, Andreasen, S R, Madsen, L W, Lindvig, S O, Øvrehus, A, Ostrowski, S R, Abildgaard, C, Matthews, C, Jensen, T O, Raben, D, Erikstrup, C, Fischer, T K, Tolstrup, M, Østergaard, L, Lundgren, J & ENFORCE Writing Group 2022, ' Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity : the Danish Nationwide ENFORCE Study ', Clinical Microbiology and Infection, vol. 28, no. 8, pp. 1126-1133 . https://doi.org/10.1016/j.cmi.2022.03.003
Søgaard, O S, Reekie, J, Johansen, I S, Nielsen, H, Benfield, T, Wiese, L, Stærke, N B, Iversen, K, Fogh, K, Bodilsen, J, Iversen, M, Knudsen, L S, Klastrup, V, Larsen, F D, Andersen, S D, Hvidt, A K, Andreasen, S R, Madsen, L W, Lindvig, S O, Øvrehus, A, Ostrowski, S R, Abildgaard, C, Matthews, C, Jensen, T O, Raben, D, Erikstrup, C, Fischer, T K, Tolstrup, M, Østergaard, L, Lundgren, J & ENFORCE Writing Group 2022, ' Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity : the Danish Nationwide ENFORCE Study ', Clinical Microbiology and Infection, vol. 28, no. 4, pp. 1126-1133 . https://doi.org/10.1016/j.cmi.2022.03.003
OBJECTIVES: To identify individual characteristics associated with serological COVID-19 vaccine responsiveness and durability of vaccine-induced antibodies.METHODS: Adults without history of SARS-CoV-2 infection from the Danish population scheduled f
Autor:
Kathryn S. Hensley, Marlou J. Jongkees, Daryl Geers, Corine H. GeurtsvanKessel, Yvonne M. Mueller, Virgil A. S. H. Dalm, Grigorios Papageorgiou, Hanka Steggink, Alicja Gorska, Susanne Bogers, Jan G. den Hollander, Wouter F. W. Bierman, Luc B. S. Gelinck, Emile F. Schippers, Heidi S. M. Ammerlaan, Marc van der Valk, Marit G. A. van Vonderen, Corine E. Delsing, Elisabeth H. Gisolf, Anke H. W. Bruns, Fanny N. Lauw, Marvin A. H. Berrevoets, Kim C. E. Sigaloff, Robert Soetekouw, Judith Branger, Quirijn de Mast, Adriana J. J. Lammers, Selwyn H. Lowe, Rory D. de Vries, Peter D. Katsikis, Bart J. A. Rijnders, Kees Brinkman, Anna H. E. Roukens, Casper Rokx
Publikováno v:
Plos Medicine, 19, 10
PLoS medicine, 19(10):e1003979. Public Library of Science
Hensley, K S, Jongkees, M J, Geers, D, GeurtsvanKessel, C H, Mueller, Y M, Dalm, V A S H, Papageorgiou, G, Steggink, H, Gorska, A, Bogers, S, den Hollander, J G, Bierman, W F W, Gelinck, L B S, Schippers, E F, Ammerlaan, H S M, van der Valk, M, van Vonderen, M G A, Delsing, C E, Gisolf, E H, Bruns, A H W, Lauw, F N, Berrevoets, M A H, Sigaloff, K C E, Soetekouw, R, Branger, J, de Mast, Q, Lammers, A J J, Lowe, S H, de Vries, R D, Katsikis, P D, Rijnders, B J A, Brinkman, K, Roukens, A H E & Rokx, C 2022, ' Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands : A nationwide prospective cohort study ', PLoS Medicine, vol. 19, no. 10, e1003979, pp. e1003979 . https://doi.org/10.1371/journal.pmed.1003979
PLOS MEDICINE, 19(10):e1003979. PUBLIC LIBRARY SCIENCE
PLoS Medicine, 19(10):e1003979. Public Library of Science
PLoS Medicine, 19(10). PUBLIC LIBRARY SCIENCE
PLOS Medicine, 19(10):e1003979. Public Library of Science
Plos Medicine, 19
PLoS medicine, 19(10):e1003979. Public Library of Science
Hensley, K S, Jongkees, M J, Geers, D, GeurtsvanKessel, C H, Mueller, Y M, Dalm, V A S H, Papageorgiou, G, Steggink, H, Gorska, A, Bogers, S, den Hollander, J G, Bierman, W F W, Gelinck, L B S, Schippers, E F, Ammerlaan, H S M, van der Valk, M, van Vonderen, M G A, Delsing, C E, Gisolf, E H, Bruns, A H W, Lauw, F N, Berrevoets, M A H, Sigaloff, K C E, Soetekouw, R, Branger, J, de Mast, Q, Lammers, A J J, Lowe, S H, de Vries, R D, Katsikis, P D, Rijnders, B J A, Brinkman, K, Roukens, A H E & Rokx, C 2022, ' Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands : A nationwide prospective cohort study ', PLoS Medicine, vol. 19, no. 10, e1003979, pp. e1003979 . https://doi.org/10.1371/journal.pmed.1003979
PLOS MEDICINE, 19(10):e1003979. PUBLIC LIBRARY SCIENCE
PLoS Medicine, 19(10):e1003979. Public Library of Science
PLoS Medicine, 19(10). PUBLIC LIBRARY SCIENCE
PLOS Medicine, 19(10):e1003979. Public Library of Science
Plos Medicine, 19
Background: Vaccines can be less immunogenic in people living with HIV (PLWH), but for SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the vaccines currently approved in the Netherlands, the immunogenicity and re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92fd9afeac90a4baf1eeb0c1b0d42354
Autor:
Filipe Ferreira, Margarida Archer, Maria João Amorim, Diogo Athayde, Fátima Serrano, Helena Soares, A. Margarida Juliano, Nádia Charepe, Marta Alenquer, Juliana Gonçalves
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Cell Reports Medicine
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Cell Reports Medicine
In view of the scarcity of data to guide decision making, we evaluated how BNT162b2 and mRNA-1273 vaccines affect the immune response in lactating women and the protective profile of breastmilk. Compared with controls, lactating women had a higher fr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0697d0233892737494159ff341ef8be
Publikováno v:
Petersen, E, Gökengin, D, Al Balushi, A & Zumla, A 2021, ' One and a half years into the COVID-19 pandemic-exit strategies and efficacy of SARS-CoV-2 vaccines for holistic management and achieving global control ', Turkish journal of medical sciences, vol. 51, no. 7, 3, pp. 3157-3161 . https://doi.org/10.3906/sag-2106-236
Turkish Journal of Medical Sciences
Turkish Journal of Medical Sciences
One and a half years into the pandemic, SARS-CoV-2 is still here to stay. Whilst rapid several effective COVID-19 vaccines have been developed and are being rolled out, the critical questions remain whether vaccines provide widespread protection agai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2276b7c6cc7bf6ac002da2ed60c67e3
https://pure.au.dk/portal/da/publications/one-and-a-half-years-into-the-covid19-pandemic--exit-strategies-and-efficacy-of-sarscov2-vaccines-for-holistic-management-and-achieving-global-control(644a064c-bda8-423e-9e93-02b78f4e4db5).html
https://pure.au.dk/portal/da/publications/one-and-a-half-years-into-the-covid19-pandemic--exit-strategies-and-efficacy-of-sarscov2-vaccines-for-holistic-management-and-achieving-global-control(644a064c-bda8-423e-9e93-02b78f4e4db5).html
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE, Vol 16, Iss 11, p e0259990 (2021)
Sinclair, D, Maharani, A, Daniel, S, Welsh, C & Matthews, F E 2021, ' Can vaccination roll-out be more equitable if population risk is taken into account? ', PL o S One, vol. 16, no. 11, e0259990, pp. 1-10 . https://doi.org/10.1371/journal.pone.0259990
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE, Vol 16, Iss 11, p e0259990 (2021)
Sinclair, D, Maharani, A, Daniel, S, Welsh, C & Matthews, F E 2021, ' Can vaccination roll-out be more equitable if population risk is taken into account? ', PL o S One, vol. 16, no. 11, e0259990, pp. 1-10 . https://doi.org/10.1371/journal.pone.0259990
Background COVID-19 vaccination in many countries, including England, has been prioritised primarily by age. However, people of the same age can have very different health statuses. Frailty is a commonly used metric of health and has been found to be
Autor:
Nana-Marie Lemm, Sabina Ikram, Jessica Poppy Jane Larwood, Katherine R. W. Emary, Saul N. Faust, Savviz Mehdipour, Rajeka Lazarus, Hazel Morrison, Robert Shaw, Michael Schumacher, Katarina M Pollock, Poppy Iveson, Paul T. Heath, Mihaela Pacurar, Eva P. Galiza, Daniel R Owens, Susanne H. Hodgson, Catherine Cosgrove, Sophie Roche, Andrew J. Pollard
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 15, Iss 2, Pp 524-534 (2022)
Hodgson, S H, Iveson, P, Larwood, J, Roche, S, Morrison, H, Cosgrove, C, Galiza, E, Ikram, S, Lemm, N-M, Mehdipour, S, Owens, D, Pacurar, M, Schumacher, M, Shaw, R H, Faust, S N, Heath, P T, Pollard, A J, Emary, K R W, Pollock, K M & Lazarus, R 2022, ' Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial ', Clinical and Translational Science, vol. 15, no. 2, pp. 524-534 . https://doi.org/10.1111/cts.13170
Clinical and Translational Science, Vol 15, Iss 2, Pp 524-534 (2022)
Hodgson, S H, Iveson, P, Larwood, J, Roche, S, Morrison, H, Cosgrove, C, Galiza, E, Ikram, S, Lemm, N-M, Mehdipour, S, Owens, D, Pacurar, M, Schumacher, M, Shaw, R H, Faust, S N, Heath, P T, Pollard, A J, Emary, K R W, Pollock, K M & Lazarus, R 2022, ' Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial ', Clinical and Translational Science, vol. 15, no. 2, pp. 524-534 . https://doi.org/10.1111/cts.13170
The safety of novel therapeutics and vaccines are typically assessed in early phase clinical trials involving “healthy volunteers.” Abnormalities in such individuals can be difficult to interpret and may indicate previously unrecognized medical c
Autor:
Arnaud Del Bello, Jacques Izopet, Nassim Kamar, Laure Esposito, Stanislas Faguer, Florence Abravanel, Chloé Couat, Olivier Marion, Anne Laure Hebral
Publikováno v:
Annals of Internal Medicine
Annals of Internal Medicine, 2021, 174 (9), pp.1336-1338. ⟨10.7326/M21-1341⟩
Annals of Internal Medicine, 2021, 174 (9), pp.1336-1338. ⟨10.7326/M21-1341⟩
International audience; Background: Recipients of solid organ transplant (SOT) are a high-risk group for severe SARS-CoV-2 infection. The mortality rate of patients with SOT during the COVID-19 pandemic has been reported to be approximately 20% (1).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f291fe1fde3b0d49f3d5e26a7c8a754
https://ut3-toulouseinp.hal.science/hal-03771121
https://ut3-toulouseinp.hal.science/hal-03771121